Devonian Health Group to Participate in Renmark’s Chicago Virtual Non-Deal Roadshow Series on Wednesday, July 17, 2024
Devonian Health Group to Participate in Renmark’s Los Angeles Virtual Non-Deal Roadshow Series on Wednesday, July 10, 2024
Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor Relations Firm
Devonian Health Group to Participate in Renmark’s Boston Virtual Non-Deal Roadshow Series on Wednesday, June 26, 2024
Devonian Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer
Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update
Devonian Announces Closing of a Private Placement of Units
Devonian Names Kathryn J. Gregory to Board of Directors and Grants Stock Options
Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada
Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan